NEAT1 and ovarian carcinoma: NEAT1 knockdown further decreased cell growth in Olaparib-treated cells, demonstrating a synergistic effect of the combination of NEAT1 silencing and chemotherapeutic drugs in ovarian cancer (Figure 10C-D​).